| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $64K | +0.0% |
| Cost of Revenue | $956K | -85.6% |
| Gross Profit | -$956K | +85.5% |
| R&D Expense | $1.4M | -6.6% |
| SG&A Expense | $8.1M | -6.3% |
| Operating Income | -$10.5M | +46.0% |
| Pre-tax Income | -$21.1M | -1101.3% |
| Net Income | -$21.1M | -1101.3% |
| EPS (Basic) | -$32.24 | -1496.0% |
| EPS (Diluted) | -$32.24 | -1496.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.0M | -68.9% |
| Short-term Investments | $3.2M | -22.5% |
| Current Assets | $9.2M | -56.7% |
| Total Assets | $11.4M | -47.5% |
| Current Liabilities | $1.6M | -60.5% |
| Total Liabilities | $1.7M | -82.1% |
| Stockholders' Equity | $3.7M | -20.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.7M | +42.2% |
| Capital Expenditures | $199K | +0.0% |
| Investing Cash Flow | -$2.9M | +6.7% |
| Financing Cash Flow | -$552K | +94.9% |
| Free Cash Flow | -$7.9M | +41.6% |